TY - JOUR
T1 - Ablative therapy for movement disorders
T2 - Complications in the treatment of movement disorders
AU - Louw, D. F.
AU - Burchiel, K. J.
PY - 1998
Y1 - 1998
N2 - Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.
AB - Presently, there is a renaissance in the surgical treatment of movement disorders. Prompted by the growing recognition of the limitations of drug therapy, this resurgence has been further promoted by progress in neuronal transplantation, advances in neuroimaging and stereotactic surgical techniques, and innovative therapies, such as deep brain stimulation for abnormal movements. Mortality associated with thalamotomy and pallidotomy is rare, but morbidity is not inconsiderable, particularly in the elderly and those with preexisting brain damage. Judicious patient selection and physiologic confirmation of stereotactic targets are cornerstones to complication avoidance.
UR - http://www.scopus.com/inward/record.url?scp=0031940256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031940256&partnerID=8YFLogxK
U2 - 10.1016/s1042-3680(18)30271-7
DO - 10.1016/s1042-3680(18)30271-7
M3 - Review article
C2 - 9495898
AN - SCOPUS:0031940256
SN - 1042-3680
VL - 9
SP - 367
EP - 373
JO - Neurosurgery clinics of North America
JF - Neurosurgery clinics of North America
IS - 2
ER -